- Home
- Our Capabilities
- CDMO Services
How Teyro Works: End-to-End CDMO Solutions
Teyro simplifies pharmaceutical development with a structured CDMO (Contract Development & Manufacturing Organization) model, ensuring efficiency, compliance, and scalability from concept to commercialization.
- Home
- Our Business
- CDMO Services
How Teyro Works: End-to-End CDMO Solutions
Teyro simplifies pharmaceutical development with a structured CDMO (Contract Development & Manufacturing Organization) model, ensuring efficiency, compliance, and scalability from concept to commercialization.
World-Class USFDA & EU GMP Complaints Sterile & Non-Sterile Oncology Product Manufacturing

20+ Years
of CDMO Expertise

100+
Formulations Developed

cGMP& Global Regulatory
Approvals like USFDA, EMA (Germany), WHO and more.

Seamless
Scale-Up

Precision Manufacturing
& Testing
Our Process: From Development to Delivery
1. Research & Formulation
- Custom drug formulation for oral solids, injectables, suspensions, and complex generics.
- Process optimization for bioavailability, stability, and scalability.
- Pre-formulation studies, excipient compatibility, and prototype development.
2. Analytical & Stability Testing
- In-house laboratories for method development, validation, and ICH-compliant stability studies.
- Quality control at every stage, ensuring regulatory compliance.
- Accelerated and real-time stability testing for predictable shelf-life.
3. Scale-Up, Technology Transfer & Commercial Manufacturing
- Sterile & Non-Sterile Manufacturing for Oncology, High-potent and Specialty Formulations with multiple dosage forms like Injectable-Liquid & Lyophilized Vials, Tablets, Hard /soft Capsules, Powder.
- Scalable Production – Pilot batches to full commercial manufacturing with stringent quality assurance.
- Advanced Aseptic Production Facilities – Equipped with fully automated BOSCH Filling lines, MARTIN CHRIST Lyophilizers with Auto-Loading & Un-loading system, FEDEGARI Autoclaves,
- Compounding & Aseptic Filtration capacity for 25 Litres to 1000 Litres under Closed contained system with programmed CIP and SIP systems and facilities.
- Aseptic processing under Isolator and RABS technology integrated with BOSCH Integrated Filling line with an operating capacity of 15 million Vials per annum with a aseptic filling range from 1 mL to 100 mL vial sizes.
- Oral Solids processing under isolator containment equipped with GEA granulation line & Compression machine, LB Bohle Coating machine, MG2 Capsule filling machine and CVC Bottle Packing line with an annual operating capacity of 150 million each tablet and capsules.
4. Regulatory & Market Readiness
- Full regulatory support, dossier preparation, and global compliance.
- End-to-end tech transfer for seamless scale-up and commercialization.
- Post-approval support, documentation, and continuous monitoring.
Beyond Manufacturing
At Teyro, CDMO is more than just manufacturing—it’s a strategic partnership. Our integrated approach ensures efficiency, cost-effectiveness, and speed without compromising quality.
Oncology Expertise.
CDMO Excellence.
Teyro Labs works as an extension of your team to deliver results that matter.
Let’s make it happen.